Our Director of Medicinal Chemistry, Dr. Walajapet Rajeswaran, in Seattle last week presenting our newly updated research on molecular glue degraders. View the poster: https://lnkd.in/gAF3FBaX #MolecularGlueDegraders #MedicinalChemistry
上海睿智化学研究有限公司
研究服务
ChemPartner is a global, full-service drug discovery, development, and manufacturing CRO/CDMO.
关于我们
who are we : Chempartner is an innovative company adhering to the principle of “Science First, Technology Leads,” providing integrated services for pharmaceutical research and production (CRO+CDMO). It has developed advanced technological capabilities, assembled top-tier scientists, and equipped itself with state-of-the-art research, animal testing, and pharmaceutical intermediate production facilities. Vision Statement: We strive to ensure that all drugs can be produced and every disease can be addressed by creating an open-access platform equipped with the most advanced capabilities and technologies in the global pharmaceutical sector. Mission Statement Our goal is to revolutionize and expedite the discovery, development, and manufacturing of pharmaceuticals. By providing a comprehensive open-access platform, we empower our global healthcare partners and improve patient outcomes around the world. Our PROUD Culture Passion: Committed to customer satisfaction, continuous innovation, and a vibrant, energetic workplace. Responsibility: Embracing accountability, handling challenging tasks with integrity, and contributing to the community. Open Culture: Promoting teamwork, diversity, inclusion, and transparent communication. R&D Focus: Prioritizing research and development, advancing scientific excellence, and fostering innovation.
- 网站
-
http://www.chempartner.com
上海睿智化学研究有限公司的外部链接
- 所属行业
- 研究服务
- 规模
- 1,001-5,000 人
- 总部
- Shanghai
- 类型
- 上市公司
- 创立
- 2002
- 领域
- Biologics、Oncology、Neuroscience、Drug Development、CRO、Drug Discovery、Antibody Generation、CDMO、CMC Manufacturing、In Vitro、In Vivo、Discovery Chemistry、Biologics Manufacturing、DMPK、ADME、Exploratory Toxicology、Biologics Discovery、Medicinal Chemistry、Synthetic Chemistry和Pharmacology
地点
上海睿智化学研究有限公司员工
动态
-
Looking for an innovative oncology event in July? Come see our VP of Biology and Pharmacology, Yinfei Yin, PhD introduce our comprehensive platform for PROTAC evaluation at Tumor Models in Boston. Schedule a time to meet with us at the event: https://lnkd.in/exuuP8uv #TumorModelsBoston #Oncology #PROTAC
-
Find us in Boston tomorrow at a PBSS event talking all things preclinical development and IND filing for small molecules. Find us at other upcoming events: https://lnkd.in/exuuP8uv #Preclinical #INDFiling Christine Daly Erick Juarez
Let's Meet
chempartner.com
-
We're ready to help you develop novel therapeutic strategies for combating brain cancer with our in vivo orthotopic and metastatic models. Chat with a scientist today: https://lnkd.in/d7rKdUxQ #BrainTumor #OncologyResearch #DrugDevelopment
-
Find our Director of Medicinal Chemistry, Walajapet Rajeswaran, PhD, in Seattle next week with our latest poster on molecular glue degraders at the 38th ACS National Medicinal Chemistry Symposium. Check out other exciting upcoming events: https://lnkd.in/exuuP8uv #MolecularGlueDegraders #MedicinalChemistry
Join Us
chempartner.com
-
Reduce lead times for assessing drug candidates via our cyclophosphamide-induced type 1 diabetic mouse model: ✅ Fast ✅ Reliable ✅ Clinically Relevant Chat with a scientist today: https://lnkd.in/d7rKdUxQ #Diabetes #DrugDevelopment
-
Short lead times and a variety of validated models means a fast and cost-effective platform for your irradiation research. ✅ Tumor targeted radiation to specific sites ✅ Whole body irradiation – myeloablation/sublethal radiation ✅ Combination treatment approaches Chat with a scientist today: https://lnkd.in/d7rKdUxQ #Oncology #Irradiation
-
Every year we go to PEGS in Boston, and every year we have a great time! If you missed us, don't worry, we will be back in July for Tumor Models Boston, where our VP of Biology and Pharmacology will be introducing a comprehensive platform for PROTAC evaluation. Request a poster from one of our recent events here: https://lnkd.in/gYEHD25e
-
-
Our team in the US is growing! If you're passionate about research and are experienced in business development, we want to hear from you! Apply here or at https://lnkd.in/gJSpnmV7 to chat about joining us as our Director/Associate Director/Manager of Business Development: https://lnkd.in/gbMuj9fm
-
Accelerate the approval process for new psoriasis treatments via the IL-23-induced psoriasis model: ✅ Cost-effective ✅ Fast ✅ Validated model Get your psoriasis treatment to patients faster: https://lnkd.in/exuuP8uv #DrugDiscovery #Psoriasis